SynthesisBMC pharmacology & toxicology2019

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.